Biocon shares in focus after Q3 PAT drops 96% YoY, 1.5% additional stake acquisition in subsidiary Biocon share price: Biocon ...

Maintain Reduce; Cut TP to Rs 3350 from Rs 3450 Decent performance amid demand uncertainties Sequential growth and margin expansion through FY27 Factor in higher forex losses due to long-term hedges.

Jio Platforms has replaced Kiran Thomas as chief executive officer with Pankaj Pawar, according to its draft IPO papers, as ...

Top picks for Monday, July 13 include Biocon, TSF Investments, Neogen Chemicals, Triveni Engineering & Industries, and DOMS ...

Read all the latest news headline updates on Dabur India. Get all the Dabur India breaking news updates, videos, photostories and more at Business Standard.

Drugmaker Biocon Ltd is aiming to become the world’s top supplier of insulin in the coming years, the company’s co-founder Kiran Mazumdar-Shaw said, by capturing the growing demand for the critical ...

Biocon Academy, a Centre of Excellence for Advanced Learning in Applied Biosciences, hosted its 10th graduation ceremony at its Bengaluru campus, with 156 students graduating this year. Seven ...

Biocon seeks in-licensing deals to expand biosimilars portfolio. In-licensing speeds Biocon launches and fills portfolio gaps Biosimilars segment grew 16 percent in FY26, core growth engine. Biocon is ...

Biocon founder and chairperson Kiran Mazumdar-Shaw’s recent announcement of a phased, five-year succession plan, involving naming her niece, Claire Mazumdar, as her successor, marked a pivotal ...

AI Quick Read New biosimilar launches and scaling up of recently launched products are expected to drive growth for Biocon in FY27, as the company pivots from a heavy investment phase towards ...

Pharma major Biocon Limited has reported a 56.8 per cent year-on-year (y-o-y) decline in consolidated net profit to ₹198.6 crore for Q4FY26, impacted by an exceptional item outgo of ₹80.4 crore during ...